Dr. Manika Khanna, Chairperson and MD,Announces Gaudium IVF IPO Launch; Expansion of Fertility Network in Focus
Gaudium IVF and Women Health Limited IPO to Open on February 20, 2026
Bilkul Bazaar | By Rafat Quadri
Ahmedabad | 19 Feb 2026
In a country where millions of couples quietly struggle with infertility and the emotional weight that often accompanies it, healthcare institutions dedicated to reproductive medicine play a deeply meaningful role. Gaudium IVF and Women Health Limited, a company focused on fertility care and women’s health services, is now taking a significant step in its growth journey with the launch of its Initial Public Offering (IPO), aiming to expand access to advanced IVF treatment across India.
The IPO will open for subscription on Friday, February 20, 2026, and close on Tuesday, February 24, 2026, while the anchor investor bidding will take place on February 19, 2026. The company has fixed a price band of ₹75 to ₹79 per equity share (face value ₹5), with applications permitted in a minimum lot of 189 shares and multiples thereafter.
The public issue consists of a fresh issue of up to 1,13,92,500 equity shares along with an offer for sale of up to 94,93,700 shares by the promoter selling shareholder. The equity shares are proposed to be listed on the BSE Limited and the National Stock Exchange of India Limited, with NSE serving as the designated stock exchange. Sarthi Capital Advisors Private Limited is acting as the sole Book Running Lead Manager to the issue.
According to the company, the net proceeds from the fresh issue will primarily be used for establishing new IVF centres, repayment or prepayment of certain outstanding loans, and general corporate purposes, strengthening the company’s clinical presence and widening access to fertility care.
During an interaction with the media in Ahmedabad, the leadership team shared their vision for the company’s next phase of growth. Dr. Manika Khanna, Chairperson and Managing Director, said, “Our mission has always been to bring hope and advanced fertility solutions to families across India. The IPO will enable us to expand our IVF network, invest in advanced technologies, and reach more couples who need compassionate and specialized care.”
Vishad Khanna, Non-Executive Director, added, “This public offering represents an important milestone in Gaudium IVF’s journey. We aim to build a strong, sustainable healthcare platform focused on clinical excellence and patient trust.”
Rakesh Kumar Sharma, Chief Financial Officer, noted, “The funds raised will support expansion, strengthen our balance sheet through loan repayments, and position the company for long-term, responsible growth.”
From the issue’s lead manager, Viren Kanojia, Senior Analyst at Sarthi Capital Advisors Private Limited, commented, “Gaudium IVF operates in a fast-growing segment of healthcare with increasing demand for fertility services, and the company’s expansion strategy is aligned with the rising need for specialized reproductive care in India.”
As Gaudium IVF prepares to enter the public markets, the offering reflects not only a financial milestone but also a broader healthcare commitment—expanding access to advanced fertility treatments and supporting countless families in their journey toward parenthood. For many hopeful parents, the growth of institutions dedicated to women’s health and reproductive care continues to symbolize renewed possibility, resilience, and the promise of new beginnings.
Gaudium IVF and Women Health Limited – IPO Snapshot
| Particulars | Details |
| IPO Opening Date | February 20, 2026 |
| IPO Closing Date | February 24, 2026 |
| Anchor Investor Bidding | February 19, 2026 |
| Price Band | ₹75 – ₹79 per equity share |
| Face Value | ₹5 per share |
| Lot Size | 189 shares (and multiples thereafter) |
| Issue Type | Book Built Issue |
| Fresh Issue Size | Up to 1,13,92,500 equity shares |
| Offer for Sale (OFS) | Up to 94,93,700 equity shares |
| Listing | BSE Limited & NSE (Designated Exchange: NSE) |
| Lead Manager | Sarthi Capital Advisors Pvt. Ltd. |
| Minimum Retail Investment (Upper Band) | ₹14,931 (189 shares × ₹79) |
| Objects of the Issue | New IVF centers expansion, loan repayment/prepayment, general corporate purposes |
Key takeaway: The IPO aims to fund expansion of new IVF centres and strengthen the company’s financial position while supporting wider access to fertility and women’s healthcare services across India.
If you want, I can also prepare a subscription-decision checklist (valuation, strengths, risks, peer comparison) in a short investor-friendly format.
Disclaimer: This news is for informational purposes only. Please refer to official offer documents and consult a financial advisor before investing.
Kindly Like the shared links and Subscribe our channel for such valuable updates. https://youtube.com/shorts/BEfg2V3gahE?feature=share https://youtu.be/0ZRFx3Lhtqs